| Subject ID, age, height, weight, tumor grade, tumor stage, histology of tumor, tumor ER, HER2, and PR status, menopause status, tumor progression and death of participants with primary breast cancer and involved in the \"Simultaneous Study of Gemcitabine-Docetaxel Combination Adjuvant Treatment, as Well as Extended Bisphosphonate and Surveillance-Trial (SUCCESS-Trial)\" project. | PN according to TNM Classification | phv00174070.v1.p1 |
| Subject ID, age, height, weight, tumor grade, tumor stage, histology of tumor, tumor ER, HER2, and PR status, menopause status, tumor progression and death of participants with primary breast cancer and involved in the \"Simultaneous Study of Gemcitabine-Docetaxel Combination Adjuvant Treatment, as Well as Extended Bisphosphonate and Surveillance-Trial (SUCCESS-Trial)\" project. | Weight (to calculate BMI) | phv00174067.v1.p1 |
| Subject ID, age, height, weight, tumor grade, tumor stage, histology of tumor, tumor ER, HER2, and PR status, menopause status, tumor progression and death of participants with primary breast cancer and involved in the \"Simultaneous Study of Gemcitabine-Docetaxel Combination Adjuvant Treatment, as Well as Extended Bisphosphonate and Surveillance-Trial (SUCCESS-Trial)\" project. | Age at randomization | phv00174064.v1.p1 |
| Subject ID, age, height, weight, tumor grade, tumor stage, histology of tumor, tumor ER, HER2, and PR status, menopause status, tumor progression and death of participants with primary breast cancer and involved in the \"Simultaneous Study of Gemcitabine-Docetaxel Combination Adjuvant Treatment, as Well as Extended Bisphosphonate and Surveillance-Trial (SUCCESS-Trial)\" project. | Observation time for overall survival | phv00174073.v1.p1 |
| Sample ID, body site where sample was collected, analyte type of samples, tumor status, and histological type of samples obtained from participants with primary breast cancer and involved in the \"Simultaneous Study of Gemcitabine-Docetaxel Combination Adjuvant Treatment, as Well as Extended Bisphosphonate and Surveillance-Trial (SUCCESS-Trial)\" project. | Analyte type | phv00174083.v1.p1 |
| Subject ID, age, height, weight, tumor grade, tumor stage, histology of tumor, tumor ER, HER2, and PR status, menopause status, tumor progression and death of participants with primary breast cancer and involved in the \"Simultaneous Study of Gemcitabine-Docetaxel Combination Adjuvant Treatment, as Well as Extended Bisphosphonate and Surveillance-Trial (SUCCESS-Trial)\" project. | Is there a grade 3 or grade 4 AE (leukopenia, neutropenia or febrile neutropenia) within chemo cycles 4,5,6 (yes/no)? | phv00174080.v1.p1 |
| Sample ID, subject ID, sample source, sample source ID, and sample use variables obtained from participants with primary breast cancer and involved in the \"Simultaneous Study of Gemcitabine-Docetaxel Combination Adjuvant Treatment, as Well as Extended Bisphosphonate and Surveillance-Trial (SUCCESS-Trial)\" project. | Sample ID used in the Source Repository | phv00174057.v1.p1 |
| Subject ID, consent group, subject source, and subject source ID of participants with primary breast cancer and involved in the \"Simultaneous Study of Gemcitabine-Docetaxel Combination Adjuvant Treatment, as Well as Extended Bisphosphonate and Surveillance-Trial (SUCCESS-Trial)\" project. | Subject ID used in the Source Repository | phv00174048.v1.p1 |
| Sample ID, subject ID, sample source, sample source ID, and sample use variables obtained from participants with primary breast cancer and involved in the \"Simultaneous Study of Gemcitabine-Docetaxel Combination Adjuvant Treatment, as Well as Extended Bisphosphonate and Surveillance-Trial (SUCCESS-Trial)\" project. | GENEVA ID | phv00174054.v1.p1 |
| Subject ID, family ID, father and mother IDs, and sex of participants with primary breast cancer and involved in the \"Simultaneous Study of Gemcitabine-Docetaxel Combination Adjuvant Treatment, as Well as Extended Bisphosphonate and Surveillance-Trial (SUCCESS-Trial)\" project. | Father ID | phv00174051.v1.p1 |
| Subject ID, age, height, weight, tumor grade, tumor stage, histology of tumor, tumor ER, HER2, and PR status, menopause status, tumor progression and death of participants with primary breast cancer and involved in the \"Simultaneous Study of Gemcitabine-Docetaxel Combination Adjuvant Treatment, as Well as Extended Bisphosphonate and Surveillance-Trial (SUCCESS-Trial)\" project. | Is there a grade 3 or grade 4 AE (leukopenia, neutropenia or febrile neutropenia) within chemo cycles 1,2,3 (yes/no)? | phv00174078.v1.p1 |
| Sample ID, body site where sample was collected, analyte type of samples, tumor status, and histological type of samples obtained from participants with primary breast cancer and involved in the \"Simultaneous Study of Gemcitabine-Docetaxel Combination Adjuvant Treatment, as Well as Extended Bisphosphonate and Surveillance-Trial (SUCCESS-Trial)\" project. | De-identified sample ID | phv00174081.v1.p1 |
| Subject ID, age, height, weight, tumor grade, tumor stage, histology of tumor, tumor ER, HER2, and PR status, menopause status, tumor progression and death of participants with primary breast cancer and involved in the \"Simultaneous Study of Gemcitabine-Docetaxel Combination Adjuvant Treatment, as Well as Extended Bisphosphonate and Surveillance-Trial (SUCCESS-Trial)\" project. | HER2/neu status | phv00174062.v1.p1 |
| Subject ID, age, height, weight, tumor grade, tumor stage, histology of tumor, tumor ER, HER2, and PR status, menopause status, tumor progression and death of participants with primary breast cancer and involved in the \"Simultaneous Study of Gemcitabine-Docetaxel Combination Adjuvant Treatment, as Well as Extended Bisphosphonate and Surveillance-Trial (SUCCESS-Trial)\" project. | Menopausal status | phv00174065.v1.p1 |
| Sample ID, subject ID, sample source, sample source ID, and sample use variables obtained from participants with primary breast cancer and involved in the \"Simultaneous Study of Gemcitabine-Docetaxel Combination Adjuvant Treatment, as Well as Extended Bisphosphonate and Surveillance-Trial (SUCCESS-Trial)\" project. | Source repository where samples originate | phv00174056.v1.p1 |
| Subject ID, age, height, weight, tumor grade, tumor stage, histology of tumor, tumor ER, HER2, and PR status, menopause status, tumor progression and death of participants with primary breast cancer and involved in the \"Simultaneous Study of Gemcitabine-Docetaxel Combination Adjuvant Treatment, as Well as Extended Bisphosphonate and Surveillance-Trial (SUCCESS-Trial)\" project. | GARNET ID | phv00174059.v1.p1 |
| Subject ID, age, height, weight, tumor grade, tumor stage, histology of tumor, tumor ER, HER2, and PR status, menopause status, tumor progression and death of participants with primary breast cancer and involved in the \"Simultaneous Study of Gemcitabine-Docetaxel Combination Adjuvant Treatment, as Well as Extended Bisphosphonate and Surveillance-Trial (SUCCESS-Trial)\" project. | Observation time for progression-free survival | phv00174075.v1.p1 |
| Subject ID, age, height, weight, tumor grade, tumor stage, histology of tumor, tumor ER, HER2, and PR status, menopause status, tumor progression and death of participants with primary breast cancer and involved in the \"Simultaneous Study of Gemcitabine-Docetaxel Combination Adjuvant Treatment, as Well as Extended Bisphosphonate and Surveillance-Trial (SUCCESS-Trial)\" project. | Type of histology | phv00174072.v1.p1 |
| Subject ID, consent group, subject source, and subject source ID of participants with primary breast cancer and involved in the \"Simultaneous Study of Gemcitabine-Docetaxel Combination Adjuvant Treatment, as Well as Extended Bisphosphonate and Surveillance-Trial (SUCCESS-Trial)\" project. | Consent group as determined by DAC | phv00174046.v1.p1 |
| Subject ID, family ID, father and mother IDs, and sex of participants with primary breast cancer and involved in the \"Simultaneous Study of Gemcitabine-Docetaxel Combination Adjuvant Treatment, as Well as Extended Bisphosphonate and Surveillance-Trial (SUCCESS-Trial)\" project. | Family ID | phv00174049.v1.p1 |